摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-3-{4-[2-(5-乙基吡啶-2-基)乙氧基]苯基}丙酸 | 674798-32-4

中文名称
2-溴-3-{4-[2-(5-乙基吡啶-2-基)乙氧基]苯基}丙酸
中文别名
——
英文名称
2-bromo-3-{4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}propionic acid
英文别名
2-Bromo-3-[4-(2-(5-ethyl-2-pyridyl)ethoxy)phenyl]-propionic acid;2-bromo-3-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]propanoic acid
2-溴-3-{4-[2-(5-乙基吡啶-2-基)乙氧基]苯基}丙酸化学式
CAS
674798-32-4
化学式
C18H20BrNO3
mdl
——
分子量
378.266
InChiKey
KRNFKKYGUXBJQH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    509.7±50.0 °C(Predicted)
  • 密度:
    1.379±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    23
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    59.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Method for obtaining pioglitazone as an antidiabetic agent
    申请人:Halama Ales
    公开号:US20050043360A1
    公开(公告)日:2005-02-24
    A method for obtaining antidiabetic of formula (I), wherein the method comprises condensing of a 4-derivatized phenol or phenolate of general formula (II), wherein R is an amino group-containing organic residue, selected from the group comprising a residue of the following formula —NHR 3 , wherein R 3 is hydrogen or a protecting group, which is removed before further treatment, and a residue of general formula (A), wherein R b represents a carboxy group either in the free acid form or in the form of a salt or ester or another functional derivative or the nitrile group CN, and M represents a hydrogen or alkali metal atom, with a pyridine base of general formula (III, wherein Z is a leaving group other than a halogen, wherein, before or after carrying out the condensation, the following operations are carried out: (a) diazotizing the amino group present in organic residue R; (b) converting the diazotised residue R into a derivative of 2-halopropionate or 2-halopropionitrile of formula (B), wherein R b is as defined above and X is a halogen; (c) cyclizing the derivative of 2-halopropionate or 2-halopropionitrile with thiourea; (d) hydrolysing the resulting imine thus giving pioglitazone of formula (I).
    一种获得式(I)抗糖尿病药物的方法,其中该方法包括将通式(II)的4-取代酸盐与通式(III)的吡啶碱缩合,其中R是含有基的有机残基,所选残基包括以下公式的残基:—NHR3,其中R3是或保护基,在进一步处理之前去除;以及通式(A)的残基,其中Rb表示自由酸形式或盐或或其他官能衍生物形式的羧基,或者是腈基CN,M表示或碱属原子,Z表示离去基,不是卤素,缩合前或缩合后进行以下操作:(a)重化有机残基R中存在的基;(b)将重化的残基R转化为2-卤代丙酸或2-卤代丙腈的衍生物(B),其中Rb如上定义,X为卤素;(c)与硫脲环化2-卤代丙酸或2-卤代丙腈的衍生物;(d)解得到式(I)的吡格列酮
  • Processes for making thiazolidinedione derivatives and compounds thereof
    申请人:Pospisilik Karel
    公开号:US20050059708A1
    公开(公告)日:2005-03-17
    A compound of the formula: wherein A represents a ring group connected to the oxygen atom by a C 1 to C 6 hydrocarbon chain, R is hydrogen or a C 1 -C 4 alkyl, and Q is hydrogen, or an amine protecting group such as acetyl, trifluoroacetyl, benzoyl, benzyl, or trityl, is useful in making thiazolidinedione derivatives such as pioglitazone, rosiglitazone and troglitazone.
    公式为:其中A代表通过C1到C6链连接到原子的环基团,R为或C1-C4烷基,Q为基保护基,例如乙酰基、三氟乙酰基、甲酰基、苄基或三甲基。该化合物可用于制备噻唑烷二生物,如吡格列酮罗格列酮曲格列酮
  • Thiazolidinedione derivatives, their production and use
    申请人:Takeda Chemical Industries, Ltd.
    公开号:EP0193256B1
    公开(公告)日:1989-04-05
  • METHOD FOR OBTAINING PIOGLITAZONE AS AN ANTIDIABETIC AGENT
    申请人:Zentiva, a.s.
    公开号:EP1387843B1
    公开(公告)日:2007-02-28
  • EP1622898A1
    申请人:——
    公开号:EP1622898A1
    公开(公告)日:2006-02-08
查看更多